Solid Biosciences Stock Price. Everything You Need To Know About The Solid Biosciences Stock!
Solid Biosciences, Inc. is a biotechnology company headquartered in Charlestown, Massachusetts, with 87 full-time employees. The company focuses on developing treatments for patients with Duchenne muscular dystrophy (DMD), a genetic disorder characterized by muscle degeneration and weakness.
Solid Biosciences’ gene transfer candidates, SGT-001 and SGT-003, are designed to address the underlying genetic cause of Duchenne by delivering a synthetic transgene that produces dystrophin-like protein only expressed in muscles of the body, including cardiac and respiratory muscles. The company’s neuromuscular and cardiac programs include SGT-003, a differentiated gene transfer candidate for the treatment of Duchenne, AVB-202, a gene transfer candidate for the treatment of Friedreich’s ataxia, and AVB-401 for BAG3 mediated dilated cardiomyopathy.
In addition to gene transfer candidates, the company has development programs focused on platform technologies, including novel capsid libraries and dual gene expression, which allows for multiple transgenes to be packaged into one vector.
As investors consider the potential of Solid Biosciences, it’s important to keep track of stock movements and stocks share price today, as well as premarket trends. While we cannot provide specific investment advice or recommend this stock over others, conducting thorough research and consulting with a financial advisor can help investors make informed decisions about their portfolios. It’s also essential to stay informed about industry news and events that may impact the company’s performance.
Solid Biosciences Stock Price. Everything You Need To Know About The Solid Biosciences Stock! performance
- Employees 87
- Company HQ Charlestown
- Website https://www.solidbio.com/
- SLDB Asset Type Common Stock
- SLDB Market Capitalization 334.9M
- Earnings Per Share -4.83
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Solid Biosciences – Investing in Revolutionary Biotech Are you from Malaysia, Thailand, Indonesia, or Vietnam and looking to make smart investments in the US stock market? Look no further than Solid Biosciences – a revolutionary biotech company that is making waves in the medical industry. Solid Biosciences is dedicated to improving the lives of individuals living with Duchenne muscular dystrophy (DMD). Through innovative research and development, they aim to provide effective treatments for this devastating genetic disease. Now, you may be wondering how you can invest in Solid Biosciences from these countries. Thankfully, with the help of Zorion’s investment platform, you can easily access real US stocks like Solid Biosciences and Pre-IPO companies. Zorion is a trusted investment platform that offers investment insights and recommendations to retail investors like you. By providing you with the necessary resources and educational materials, Zorion ensures that you make informed decisions about your investments. So, what are you waiting for? Start your investment journey today and invest in Solid Biosciences with the help of Zorion. Together, let’s make a difference in the world of biotech while securing your financial future.
